Rima, M.; Pfennigwerth, N.; Cremanns, M.; Cirnski, K.; Oueslati, S.; Gatermann, S.G.; d’Amélio, N.; Herrmann, J.; Müller, R.; Naas, T.
In Vitro Activity of Two Novel Antimicrobial Compounds on MDR-Resistant Clinical Isolates. Antibiotics 2023, 12, 1265.
https://doi.org/10.3390/antibiotics12081265
AMA Style
Rima M, Pfennigwerth N, Cremanns M, Cirnski K, Oueslati S, Gatermann SG, d’Amélio N, Herrmann J, Müller R, Naas T.
In Vitro Activity of Two Novel Antimicrobial Compounds on MDR-Resistant Clinical Isolates. Antibiotics. 2023; 12(8):1265.
https://doi.org/10.3390/antibiotics12081265
Chicago/Turabian Style
Rima, Mariam, Niels Pfennigwerth, Martina Cremanns, Katarina Cirnski, Saoussen Oueslati, Sören G. Gatermann, Nicola d’Amélio, Jennifer Herrmann, Rolf Müller, and Thierry Naas.
2023. "In Vitro Activity of Two Novel Antimicrobial Compounds on MDR-Resistant Clinical Isolates" Antibiotics 12, no. 8: 1265.
https://doi.org/10.3390/antibiotics12081265
APA Style
Rima, M., Pfennigwerth, N., Cremanns, M., Cirnski, K., Oueslati, S., Gatermann, S. G., d’Amélio, N., Herrmann, J., Müller, R., & Naas, T.
(2023). In Vitro Activity of Two Novel Antimicrobial Compounds on MDR-Resistant Clinical Isolates. Antibiotics, 12(8), 1265.
https://doi.org/10.3390/antibiotics12081265